Keywords
Last Name
Institution

Erin Weeda

Title
InstitutionMedical University of South Carolina
DepartmentSCCP Clinical Pharmacy and Outcome Sciences - MUSC Campus
AddressP.O. Box MSC 140
QE213C
Quad F - 280 Calhoun St.
Phone843-792-1186
Fax843-792-3759
vCardDownload vCard

    Collapse Overview 
    Collapse keywords
    Outcomes Research, Meta-analysis, Systematic Review, Observational Studies, Data Analysis, Pharmacy, Cardiology, Venous thromboembolism, Pulmonary Embolism, Anticoagulation, Health Economics

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Drisaldi A, Weeda E, Neyens R, Orvin N, Bonilha L, Campbell Z, Bohm N. Accuracy of Valproic Acid Concentration Correction Based on Serum Albumin. Neurocrit Care. 2018 Oct 16. PMID: 30328046.
      View in: PubMed
    2. Nguyen E, Coleman CI, Kohn CG, Weeda ER. Ranolazine in patients with type 2 diabetes and chronic angina: A cost-effectiveness analysis and assessment of health-related quality-of-life. Int J Cardiol. 2018 Sep 21. PMID: 30266352.
      View in: PubMed
    3. Weeda ER, Caranfa JT, Lyman GH, Kuderer NM, Nguyen E, Coleman CI, Kohn CG. External validation of three risk stratification rules in patients presenting with pulmonary embolism and cancer. Support Care Cancer. 2018 Aug 08. PMID: 30090992.
      View in: PubMed
    4. Sobieraj DM, Weeda ER, Nguyen E, Coleman CI, White CM, Lazarus SC, Blake KV, Lang JE, Baker WL. Association of Inhaled Corticosteroids and Long-Acting ß-Agonists as Controller and Quick Relief Therapy With Exacerbations and Symptom Control in Persistent Asthma: A Systematic Review and Meta-analysis. JAMA. 2018 04 10; 319(14):1485-1496. PMID: 29554195.
      View in: PubMed
    5. Sobieraj DM, Baker WL, Nguyen E, Weeda ER, Coleman CI, White CM, Lazarus SC, Blake KV, Lang JE. Association of Inhaled Corticosteroids and Long-Acting Muscarinic Antagonists With Asthma Control in Patients With Uncontrolled, Persistent Asthma: A Systematic Review and Meta-analysis. JAMA. 2018 04 10; 319(14):1473-1484. PMID: 29554174.
      View in: PubMed
    6. ELAINE NGUYEN, ERIN R. WEEDA, CHRISTINE G. KOHN, BENJAMIN A. D’SOUZA, ANDREA M. RUSSO, STACEY NOREIKA, and CRAIG I. COLEMAN. Wearable Cardioverter-defibrillators for the Prevention of Sudden Cardiac Death: A Meta-analysis. 2018.
    7. Coleman CI, Vaitsiakhovich T, Nguyen E, Weeda ER, Sood NA, Bunz TJ, Schaefer B, Meinecke AK, Eriksson D. Agreement between coding schemas used to identify bleeding-related hospitalizations in claims analyses of nonvalvular atrial fibrillation patients. Clin Cardiol. 2018 Jan; 41(1):119-125. PMID: 29360144.
      View in: PubMed
    8. Weeda ER, Bohm N. Association between comorbid cancer and outcomes among admissions for acute ischemic stroke receiving systemic thrombolysis. Int J Stroke. 2018 Jan 01; 1747493018778135. PMID: 29762085.
      View in: PubMed
    9. Nguyen E, Caranfa JT, Lyman GH, Kuderer NM, Stirbis C, Wysocki M, Coleman CI, Weeda ER, Kohn CG. Clinical prediction rules for mortality in patients with pulmonary embolism and cancer to guide outpatient management: a meta-analysis. J Thromb Haemost. 2017 Dec 07. PMID: 29215781.
      View in: PubMed
    10. Weeda ER, Caranfa JT, Zeichner SB, Coleman CI, Nguyen E, Kohn CG. External Validation of Generic and Cancer-Specific Risk Stratification Tools in Patients With Pulmonary Embolism and Active Cancer. J Natl Compr Canc Netw. 2017 Dec; 15(12):1476-1482. PMID: 29223985.
      View in: PubMed
    11. Coleman CI, Weeda ER, Nguyen E, Bunz TJ, Sood NA. Effectiveness and Safety of Rivaroxaban Versus Warfarin in Patients 80+ Years-of-Age with Nonvalvular Atrial Fibrillation. Eur Heart J Qual Care Clin Outcomes. 2017 Nov 07. PMID: 29121212.
      View in: PubMed
    12. Nguyen E, Coleman CI, Nair S, Weeda ER. Cost-utility of empagliflozin in patients with type 2 diabetes at high cardiovascular risk. J Diabetes Complications. 2018 Feb; 32(2):210-215. PMID: 29157870.
      View in: PubMed
    13. White CM, Weeda ER, Nguyen E. Should an LDL-Cholesterol Target-Based Approach Be Readopted? Ann Pharmacother. 2018 Feb; 52(2):175-184. PMID: 28915766.
      View in: PubMed
    14. Nguyen E, Coleman CI, Peacock WF, Wells PS, Weeda ER, Ashton V, Crivera C, Wildgoose P, Schein JR, Bunz TJ, Fermann GJ. Observation management of pulmonary embolism and agreement with claims-based and clinical risk stratification criteria in United States patients: a retrospective analysis. BMC Pulm Med. 2017 Feb 13; 17(1):37. PMID: 28193193.
      View in: PubMed
    15. Kohn CG, Weeda ER, Kumar N, Wells PS, Peacock WF, Fermann GJ, Wang L, Baser O, Schein JR, Crivera C, Coleman CI. External validation of a claims-based and clinical approach for predicting post-pulmonary embolism outcomes among United States veterans. Intern Emerg Med. 2017 Aug; 12(5):613-619. PMID: 28185131.
      View in: PubMed
    16. Weeda ER, Peacock WF, Fermann GJ, Baugh CW, Wells PS, Ashton V, Crivera C, Wildgoose P, Schein JR, Coleman CI. Shortened hospital length of stay and lower costs associated with rivaroxaban in patients with pulmonary embolism managed as observation status. Int J Clin Pract. 2017 Jan; 71(1). PMID: 28097761.
      View in: PubMed
    17. Weeda ER, Peacock WF, Fermann GJ, Wells PS, Ashton V, Crivera C, Bunz TJ, Wildgoose P, Schein JR, Coleman CI. Outcomes associated with observation stays versus inpatient admissions for pulmonary embolism. J Thromb Thrombolysis. 2016 Nov; 42(4):513-9. PMID: 27324143.
      View in: PubMed
    18. Coleman CI, Peacock WF, Fermann GJ, Crivera C, Weeda ER, Hull M, DuCharme M, Becker L, Schein JR. External validation of a multivariable claims-based rule for predicting in-hospital mortality and 30-day post-pulmonary embolism complications. BMC Health Serv Res. 2016 10 22; 16(1):610. PMID: 27770814.
      View in: PubMed
    19. Weeda ER, Wells PS, Peacock WF, Fermann GJ, Baugh CW, Ashton V, Crivera C, Wildgoose P, Schein JR, Coleman CI. Hospital length-of-stay and costs among pulmonary embolism patients treated with rivaroxaban versus parenteral bridging to warfarin. Intern Emerg Med. 2017 Apr; 12(3):311-318. PMID: 27757790.
      View in: PubMed
    20. Weeda ER, Kohn CG, Peacock WF, Fermann GJ, Crivera C, Schein JR, Coleman CI. Rivaroxaban versus Heparin Bridging to Warfarin Therapy: Impact on Hospital Length of Stay and Treatment Costs for Low-Risk Patients with Pulmonary Embolism. Pharmacotherapy. 2016 Oct; 36(10):1109-1115. PMID: 27548074.
      View in: PubMed
    21. Weeda ER, Nicoll BS, Coleman CI, Sharovetskaya A, Baker WL. Association between weekend admission and mortality for upper gastrointestinal hemorrhage: an observational study and meta-analysis. Intern Emerg Med. 2017 Mar; 12(2):163-169. PMID: 27534406.
      View in: PubMed
    22. Weeda ER, Wells PS, Peacock WF, Fermann GJ, Baugh CW, Ashton V, Crivera C, Wildgoose P, Schein JR, Coleman CI. Outcomes associated with observation status versus inpatient management of pulmonary embolism patients anticoagulated with rivaroxaban. Int J Cardiol. 2016 Nov 01; 222:846-849. PMID: 27522388.
      View in: PubMed
    23. Coleman CI, Fermann GJ, Weeda ER, Wells PS, Ashton V, Crivera C, Bunz TJ, Wildgoose P, Schein JR, Peacock WF. Is Rivaroxaban Associated With Shorter Hospital Stays and Reduced Costs Versus Parenteral Bridging to Warfarin Among Patients With Pulmonary Embolism? Clin Appl Thromb Hemost. 2017 Oct; 23(7):830-837. PMID: 27481875.
      View in: PubMed
    24. Coleman CI, Peacock WF, Weeda ER, Ashton V, Fermann GJ. Outcomes related to variation in hospital pulmonary embolus observation stay utilization. Hosp Pract (1995). 2016 Aug; 44(3):133-7. PMID: 27181876.
      View in: PubMed
    25. Weeda ER, Kohn CG, Peacock WF, Fermann GJ, Crivera C, Schein JR, Coleman CI. External Validation of the Hestia Criteria for Identifying Acute Pulmonary Embolism Patients at Low Risk of Early Mortality. Clin Appl Thromb Hemost. 2017 Oct; 23(7):769-774. PMID: 27225840.
      View in: PubMed
    26. Weeda ER, Coleman CI, McHorney CA, Crivera C, Schein JR, Sobieraj DM. Impact of once- or twice-daily dosing frequency on adherence to chronic cardiovascular disease medications: A meta-regression analysis. Int J Cardiol. 2016 Aug 01; 216:104-9. PMID: 27144286.
      View in: PubMed
    27. Nguyen E, Weeda ER, Sobieraj DM, Bookhart BK, Piech CT, Coleman CI. Impact of non-medical switching on clinical and economic outcomes, resource utilization and medication-taking behavior: a systematic literature review. Curr Med Res Opin. 2016 07; 32(7):1281-90. PMID: 27033747.
      View in: PubMed
    28. Weeda ER, White CM, Peacock WF, Coleman CI. Rates of major bleeding with rivaroxaban in real-world studies of nonvalvular atrial fibrillation patients: a meta-analysis. Curr Med Res Opin. 2016 06; 32(6):1117-20. PMID: 26934003.
      View in: PubMed
    29. Weeda ER, Kohn CG, Fermann GJ, Peacock WF, Tanner C, McGrath D, Crivera C, Schein JR, Coleman CI. External validation of prognostic rules for early post-pulmonary embolism mortality: assessment of a claims-based and three clinical-based approaches. Thromb J. 2016; 14:7. PMID: 26977136; PMCID: PMC4790043.
    30. Weeda ER, Nguyen E, White CM. Role of Ivabradine in the Treatment of Patients With Cardiovascular Disease. Ann Pharmacother. 2016 Jun; 50(6):475-85. PMID: 26917820.
      View in: PubMed
    31. Rozjabek HM, Coleman CI, Weeda ER, Peacock WF, Fermann GJ, Crivera C, Schein JR, Kohn CG. Effect of vital sign measurement timing on Pulmonary Embolism Severity Index (PESI) and simplified PESI 30-day mortality risk determination. Thromb Res. 2016 May; 141:8-10. PMID: 26946105.
      View in: PubMed
    32. Nguyen E, Weeda ER, White CM. A Review of New Pharmacologic Treatments for Patients With Chronic Heart Failure With Reduced Ejection Fraction. J Clin Pharmacol. 2016 08; 56(8):936-47. PMID: 26626162.
      View in: PubMed
    33. Weeda ER, Hodgdon N, Do T, Unachukwu K, Cui A, Lundbye JB, Coleman CI. Association between weekend admission for atrial fibrillation or flutter and in-hospital mortality, procedure utilization, length-of-stay and treatment costs. Int J Cardiol. 2016 Jan 01; 202:427-9. PMID: 26433165.
      View in: PubMed
    Weeda's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _